Novel and potent 6-chloro-3-pyridinyl ligands for the α4β2 neuronal nicotinic acetylcholine receptor

被引:55
作者
Latli, B [1 ]
D'Amour, K [1 ]
Casida, JE [1 ]
机构
[1] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Environm Chem & Toxicol Lab, Berkeley, CA 94720 USA
关键词
D O I
10.1021/jm980721x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
1-[(6-Chloro-3-pyridinyl)methyl]-2-imidazolidine (1), the N-desnitro metabolite of the major insecticide imidacloprid, is known to have similar potency to that of (-)-nicotine as an inhibitor of [H-3](-)-nicotine binding at the rat recombinant alpha 4 beta 2 neuronal nicotinic acetylcholine receptor (nAChR); IC50 values in the present study are 3.8 nM for (-)-nicotine, 6.0 nM for 1, and 155 nM for imidacloprid. Synthesis of new analogues of 1, modified only in the heterocyclic moiety (five-, six-, or seven-membered rings with NH, S, O, and CH2 substituents), gave compounds varying from 4-fold higher potency (2-iminothiazole analogue 10) to > 6000-fold less active than (-)-nicotine. Other potent N-[(6-chloro-3-pyridinyl)methyl] compounds are those in which the heterocyclic imine is replaced with pyrrolidine (19) (IC50 9 nM) or trimethylammonium (22) (IC50 18 nM). A novel conversion of (-)-nicotine to its 6-chloro analogue increased the potency 2-fold. These 6-chloro-3-pyridinyl compounds are of interest as novel nAChR probes and potential metabolites of candidate insecticides.
引用
收藏
页码:2227 / 2234
页数:8
相关论文
共 53 条
[1]  
BADIO B, 1994, MOL PHARMACOL, V45, P563
[2]   Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors [J].
Bannon, AW ;
Decker, MW ;
Holladay, MW ;
Curzon, P ;
Donnelly-Roberts, D ;
Puttfarcken, PS ;
Bitner, RS ;
Diaz, A ;
Dickenson, AH ;
Porsolt, RD ;
Williams, M ;
Arneric, SP .
SCIENCE, 1998, 279 (5347) :77-81
[4]  
Chao SL, 1997, PESTIC BIOCHEM PHYS, V58, P77
[5]   (S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine Maleate (SIB-1508Y): A novel anti-Parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors [J].
Cosford, NDP ;
Bleicher, L ;
Herbaut, A ;
McCallum, JS ;
Vernier, JM ;
Dawson, H ;
Whitten, JP ;
Adams, P ;
ChavezNoriega, L ;
Correa, LD ;
Crona, JH ;
Mahaffy, LS ;
Menzaghi, F ;
Rao, TS ;
Reid, R ;
Sacaan, AI ;
Santori, E ;
Stauderman, KA ;
Whelan, K ;
Lloyd, GK ;
McDonald, IA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (17) :3235-3237
[6]  
Damaj MI, 1996, DRUG DEVELOP RES, V38, P177, DOI 10.1002/(SICI)1098-2299(199607/08)38:3/4<177::AID-DDR6>3.0.CO
[7]  
2-J
[8]  
DAMOUR KA, IN PRESS PESTIC BIOC
[9]   Pyrrolidine-modified and 6-substituted analogs of nicotine: A structure-affinity investigation [J].
Dukat, M ;
Fiedler, W ;
Dumas, D ;
Damaj, I ;
Martin, BR ;
Rosecrans, JA ;
James, JR ;
Glennon, RA .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1996, 31 (11) :875-888
[10]   SYNTHETIC ANALOGUES OF NICOTINE .1 [J].
ERDTMAN, H ;
HAGLID, F ;
WELLINGS, I .
ACTA CHEMICA SCANDINAVICA, 1963, 17 (06) :1717-+